Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Silence of Transmembrane Channel-Like 5 Inhibits Cell Proliferation, Migration, and Invasion While Promoting
Jinnan Wan1, Yang Li1, Zhimin Liu1
1Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Purpose:
Transmembrane channel-like 5 (TMC5) plays a tumor-promoting role in the progression of various tumors. However, its effect on regulating breast cancer cell function remains scarce. The current study aimed to evaluate the effect of TMC5 silence on the proliferation, apoptosis, migration, and invasion of breast cancer cell lines.
Materials And Methods:
TMC5-specific small interfering RNA (siTMC5) and siNC were transfected into MDA-MB-231 and MCF-7 cell lines; subsequently, the 740Y-P was co-cultured. Then, the proliferation, apoptosis, migration, invasion, and p-AKT expression were determined.
Results:
In MDA-MB-231 and MCF-7 cell lines, silence of TMC5 could reduce the proliferation rate at 48 hours (h) and 72 h, migration rate, and invasion rate, while elevate the apoptosis rate. Besides, silence of TMC5 could decrease the p-AKT/AKT expression. The combination of 740Y-P with the silence of TMC5 could reversely increase the proliferation rate at 48h and 72h, migration rate, and invasion rate compared with the silence of TMC5 only. The apoptosis rate showed the opposite trend.
Conclusion:
The silence of TMC5 could inhibit the proliferation, migration, and invasion while promoting the apoptosis of breast cancer, while more in vivo validation is needed to explore its potential to be a treatment target for patients with breast cancer.
Insights
Silencing Transmembrane Channel-Like 5 (TMC5) inhibits breast cancer cell proliferation, migration, and invasion while promoting apoptosis. Further in vivo studies are needed to explore TMC5 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Transmembrane Channel-Like 5 (TMC5) is implicated in tumor promotion across various cancers.
- The specific role of TMC5 in breast cancer cell function requires further elucidation.
Purpose of the Study:
- To investigate the impact of TMC5 silencing on key breast cancer cell behaviors.
- To assess the effects on proliferation, apoptosis, migration, and invasion in breast cancer cell lines.
Main Methods:
- Transfection of TMC5-specific small interfering RNA (siTMC5) into MDA-MB-231 and MCF-7 cell lines.
- Co-culture with 740Y-P and subsequent determination of proliferation, apoptosis, migration, invasion, and p-AKT expression.
Main Results:
- TMC5 silencing reduced proliferation, migration, and invasion rates while increasing apoptosis in both cell lines.
- Silencing TMC5 led to decreased p-AKT/AKT expression.
- Co-culture with 740Y-P reversed these effects, increasing proliferation, migration, and invasion while decreasing apoptosis.
Conclusions:
- TMC5 silencing demonstrates potential to inhibit breast cancer progression by reducing proliferation, migration, and invasion, and promoting apoptosis.
- Further in vivo validation is necessary to establish TMC5 as a viable therapeutic target for breast cancer treatment.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
10:39Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Abnormal Proliferation